Logo image of PRNB

Principia Biopharma Inc (PRNB) Stock Price, Forecast & Analysis

USA - NASDAQ:PRNB -

100.05
+0.1 (+0.1%)
Last: 9/25/2020, 8:00:02 PM
100.02
-0.03 (-0.03%)
After Hours: 9/25/2020, 8:00:02 PM

PRNB Key Statistics, Chart & Performance

Key Statistics
Market Cap3.32B
Revenue(TTM)50.00M
Net Income(TTM)-68.91M
Shares33.21M
Float9.50M
52 Week High101.89
52 Week Low25.35
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-2.41
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPON/A
Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A


PRNB short term performance overview.The bars show the price performance of PRNB in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 20 40 60 80

PRNB long term performance overview.The bars show the price performance of PRNB in the last 1, 2 and 3 years. 1 year 2 years 3 years 50 100 150 200

The current stock price of PRNB is 100.05 null. In the past month the price decreased by -0.81%. In the past year, price increased by 248.73%.

Principia Biopharma Inc / PRNB Daily stock chart

PRNB Latest News, Press Relases and Analysis

5 years ago - By: Investor's Business Daily - Mentions: NVS BIIB SNY MRK ...
News Image
5 years ago - By: Bloomberg
News Image
5 years ago - By: Seeking Alpha
News Image
5 years ago - By: Johnson Fistel, LLP - Mentions: SNY
News Image
5 years ago - By: Halper Sadeh LLP - Mentions: VAR PTI LVGO
News Image
5 years ago - By: Halper Sadeh LLP - Mentions: BLDR PFNX MVC
News Image
5 years ago - By: WeissLaw LLP - Mentions: PFNX
News Image
5 years ago - By: Halper Sadeh LLP - Mentions: MNTA PTI BLDR
News Image

About PRNB

Company Profile

Principia Biopharma Inc. is a clinical stage biopharmaceutical company. It offers reversible covalent small molecule drugs for the treatment of cancers. The company's product pipeline consists of PRN1008, PRN1371 and PRN2246 which are in clinical stage. Principia Biopharma Inc. is based in San Francisco, United States.

Company Info

Principia Biopharma Inc

220 East Grand Avenue

SOUTH SAN FRANCISCO CA 94080

CEO: Martin Babler

Phone: 650-416-7700

Principia Biopharma Inc / PRNB FAQ

What does Principia Biopharma Inc do?

Principia Biopharma Inc. is a clinical stage biopharmaceutical company. It offers reversible covalent small molecule drugs for the treatment of cancers. The company's product pipeline consists of PRN1008, PRN1371 and PRN2246 which are in clinical stage. Principia Biopharma Inc. is based in San Francisco, United States.


Can you provide the latest stock price for Principia Biopharma Inc?

The current stock price of PRNB is 100.05 null. The price increased by 0.1% in the last trading session.


What is the dividend status of Principia Biopharma Inc?

PRNB does not pay a dividend.


How is the ChartMill rating for Principia Biopharma Inc?

PRNB has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


PRNB Technical Analysis

ChartMill assigns a technical rating of 9 / 10 to PRNB. When comparing the yearly performance of all stocks, PRNB is one of the better performing stocks in the market, outperforming 98.45% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

PRNB Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to PRNB. While PRNB has a great health rating, there are worries on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

PRNB Financial Highlights

Over the last trailing twelve months PRNB reported a non-GAAP Earnings per Share(EPS) of -2.41. The EPS decreased by -3112.5% compared to the year before.


Industry RankSector Rank
PM (TTM) -137.82%
ROA -17.85%
ROE N/A
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%10.71%
Sales Q2Q%66.67%
EPS 1Y (TTM)-3112.5%
Revenue 1Y (TTM)-37.39%

PRNB Forecast & Estimates


Analysts
Analysts82.8
Price TargetN/A
EPS Next Y-33.49%
Revenue Next YearN/A

PRNB Ownership

Ownership
Inst Owners0.02%
Ins Owners6.47%
Short Float %N/A
Short RatioN/A